These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30899576)

  • 1. Diagnostic applications for Lassa fever in limited-resource settings.
    Emperador DM; Yimer SA; Mazzola LT; Norheim G; Kelly-Cirino C
    BMJ Glob Health; 2019; 4(Suppl 2):e001119. PubMed ID: 30899576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings.
    Mazzola LT; Kelly-Cirino C
    BMJ Glob Health; 2019; 4(Suppl 2):e001116. PubMed ID: 30899575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.
    Murphy HL; Ly H
    Virulence; 2021 Dec; 12(1):2989-3014. PubMed ID: 34747339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions.
    Arruda LB; Free HB; Simons D; Ansumana R; Elton L; Haider N; Honeyborne I; Asogun D; McHugh TD; Ntoumi F; Zumla A; Kock R
    PLOS Glob Public Health; 2023; 3(11):e0002159. PubMed ID: 37939051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
    Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine platforms for the prevention of Lassa fever.
    Purushotham J; Lambe T; Gilbert SC
    Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus.
    Cross RW; Heinrich ML; Fenton KA; Borisevich V; Agans KN; Prasad AN; Woolsey C; Deer DJ; Dobias NS; Rowland MM; Lathigra R; Borrega R; Geisbert JB; Garry RF; Branco LM; Geisbert TW
    Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2304876120. PubMed ID: 37590417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical development of a vaccine against Lassa fever.
    Banadyga L; Stein DR; Qiu X; Safronetz D
    Can Commun Dis Rep; 2018 Jun; 44(6):139-147. PubMed ID: 31015807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine platforms to control Lassa fever.
    Lukashevich IS; Pushko P
    Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
    Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria.
    Ogunro BN; Olugasa BO; Kayode A; Ishola OO; Kolawole ON; Odigie EA; Happi C
    J Epidemiol Glob Health; 2019 Jun; 9(2):125-127. PubMed ID: 31241870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Common CD8
    Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROSPECTS OF LASSA FEVER CANDIDATE VACCINES.
    Isaac AB; Karolina W; Temitope AA; Anuska R; Joanne E; Deborah A; Bianca OC; Filip T; Zofia P; Oluwasegun OI; Oluwaferanmi O; Grace BT
    Afr J Infect Dis; 2022; 16(2 Suppl):46-58. PubMed ID: 36124324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
    Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
    Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.
    Caì Y; Iwasaki M; Beitzel BF; Yú S; Postnikova EN; Cubitt B; DeWald LE; Radoshitzky SR; Bollinger L; Jahrling PB; Palacios GF; de la Torre JC; Kuhn JH
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30463334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development.
    Ibukun FI
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32244402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.
    Sogoba N; Rosenke K; Adjemian J; Diawara SI; Maiga O; Keita M; Konaté D; Keita AS; Sissoko I; Boisen M; Nelson D; Oottamasathien D; Millett M; Garry RF; Branco LM; Traoré SF; Doumbia S; Feldmann H; Safronetz D
    Emerg Infect Dis; 2016 Apr; 22(4):657-63. PubMed ID: 26981786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents.
    Smither AR; Koninga J; Kanneh FB; Foday M; Boisen ML; Bond NG; Momoh M; Sandi JD; Kanneh L; Alhasan F; Kanneh IM; Yillah MS; Grant DS; Bush DJ; Nelson DKS; Cruz KM; Klitting R; Pauthner M; Andersen KG; Shaffer JG; Cross RW; Schieffelin JS; Garry RF
    medRxiv; 2023 Mar; ():. PubMed ID: 36993465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.